While suppressed glycolysis were found in placenta of pregnant women with hyperglycemia (Valent et al. 2021), suggesting that CAMK4 overexpression may be beneficial for glycometabolism regulation although its effectiveness and safety needed to be confirmed in experimental GDM animals. This evidence concerns the gene CAMK4 and gestational diabetes.